Scientific Updates
Longhua R&D Center Laboratory Passes FDA Inspection with Zero Deficiencies
The inspection result reinforces Hybio's analytical discipline, data integrity, and global quality-system readiness.
Hybio's Longhua headquarters R&D laboratory completed a U.S. FDA on-site inspection with no deficiencies reported.
The result reflects the laboratory's focus on analytical rigor, documented processes, data integrity, and continuous quality improvement.
Quality starts in development
Reliable global supply depends on quality systems established long before commercial production begins.
Embedding compliance and traceability within R&D helps preserve scientific knowledge as methods and processes are transferred to manufacturing.
